When: Daily close above $109.94 with volume >8M shares; MACD histogram turning positive; RSI back above 50

Then: Add 1.0% of portfolio; neutralizes bearish momentum setup and re-rates technical structure

When: Confirmed breakout above $113.65 with volume >10M shares OR successful test of $103–105 zone with bullish reversal candle

Then: Add 0.5% of portfolio

Defensive HOLD: resist adding at current levels, trim 25-30% on any rally into $109-110 zone, only add on pullback to $100-102 with confirmed higher-low structure and RSI turning up, and even then with modest position size.

• Buyback "floor" thesis is dangerous—companies pause buyback programs when under stress, and history shows repurchases cluster at peaks not troughs; stock at $106.87 is up 99% over three years, exactly when buyback pace is most likely at cyclical peak
• Forward P/E of 13.7x requires 42% EPS jump from $5.49 TTM to $7.80—extraordinarily aggressive assumption; gap between 19.5x trailing P/E and 13.7x forward suggests forward estimates historically get revised lower
• MACD histogram negative for nine consecutive sessions; MACD line rolled over 70% from August peak while price only gave back 6%—textbook momentum divergence
• Stock sitting just $1.67 above 50 SMA at $105.20 with ATR of $2.21, meaning one bad macro print could trigger a cascade through the level
• P/B of 4.20x means paying for perfection—any disappointment gets amplified through multiple compression
• Risk scenario: if forward EPS estimate gets cut, 19.5x trailing becomes 22x trailing, price drops 10-15% to test 200 SMA at $96.95
• Aggressive thesis requires all assumptions to hold simultaneously: $7.80 EPS, no Fed cuts, no credit event, stable retail flows, and 50 SMA holds despite nine sessions of negative MACD

→ vs aggressive: The buyback floor thesis conflates capital return with price support—companies executed record buybacks in 2007 and 2021 and still saw stocks cut in half; buyback pace is discretionary and boards halt programs under stress

→ vs aggressive: The 0.92 PEG and 13.7x forward P/E requires a 42% EPS jump from $5.49 TTM to $7.80, an aggressive assumption that sell-side analysts are notoriously slow to downgrade when reality turns

→ vs aggressive: The dismissal of technicals is backwards—RSI collapse from 76 to 46 with nine consecutive sessions of negative MACD histogram and 10 EMA broken is a deteriorating momentum setup, not a healthy pullback

→ vs aggressive: The "higher for longer" thesis treats the absence of Fed cuts as a constant when it's a probability distribution with significant left-tail risk; the August retail activity decline of -3.9% may lead headline numbers by a quarter

→ vs aggressive: P/B of 4.20x is not a useless metric—it's a discipline check; paying 4.20x book for a financial stock means paying for perfection with no margin of safety

→ vs aggressive: IBD "buy zone" arguments are backward-looking pattern recognition, not predictive signals; grouping with Robinhood, Ameriprise, and LPL reflects similar chart patterns, not institutional accumulation

Maintain HOLD with refined parameters: stop at $104.50, trim 15-20% on rally to $109-110, add at $100-102 with stabilizing action (higher-low structure, RSI turning up, MACD histogram flattening), add on decisive reclaim above $109.94 with momentum confirmation. Do not add at $106.87.

• 42% YoY EPS ramp, 20% ROE, 52% operating margin, $3.36 billion quarterly NII run-rate with interest expense falling
• 13.7x forward P/E with PEG under 1.0 is compelling relative to cyclical financials consensus
• 93% odds priced for no cuts creates real NIM tailwind
• $10 billion annual buyback creates meaningful marginal demand but is discretionary and not an absolute floor
• P/B at 4.20x constrains multiple expansion but is not a sell trigger or irrelevant
• MACD line has rolled over 70% from peak while price gave back only 6% — path of least resistance has shifted
• Forward EPS estimate of $7.80 supported by structural drivers (deposit beta unwinding, AOCI amortization) not typical cyclical forces
• 200 SMA at $96.95 is typically a high-conviction add zone for structurally strong franchises, not capitulation level
• Conservative's 25-30% trim is too aggressive; 15-20% captures risk reduction without sacrificing asymmetric upside
• IBD buy zone signal adds modest weight to constructive thesis but doesn't justify aggressive action on its own

→ vs aggressive: Buyback is not a 'hard floor' — programs are discretionary and slow during capital stress, though $10B annual program creates meaningful asymmetric support on weakness

→ vs aggressive: P/B at 4.20x is not useless — it constrains multiple expansion and represents paying for perfection, not a verdict on the business

→ vs aggressive: Nine sessions of negative MACD with 70% rolloff from peak while price only fell 6% is a real signal — path of least resistance has shifted, not a reason to ignore technicals

→ vs aggressive: Trimming is not cowardice — it captures gains at a level where chart structure still has bounce mechanics while reducing concentration risk

→ vs conservative: 25-30% trim is too aggressive — 15-20% is the right calibration given accelerating fundamentals, supportive macro, and buyback demand

→ vs conservative: 200 SMA at $96.95 is a high-conviction add zone for a 20% ROE franchise with a buyback machine, not a level to question the thesis

→ vs conservative: Forward EPS trajectory is structural (deposit beta unwinding, AOCI amortization) not cyclical — mean reversion framework doesn't apply

→ vs conservative: IBD buy zone dismissal throws away useful information — convergence of buy zone, accelerating fundamentals, and macro tailwinds creates meaningful weight of evidence